(资料图片)

CFi.CN讯：瑞康医药（股票代码：002589）公布2025年半年度报告摘要。

本报告期上年同期本报告期比上年同期增减调整前调整后调整后营业收入（元）3,543,520,195.094,031,665,203.804,031,665,203.80-12.11%归属于上市公司股东的净利润（元）18,166,445.2831,025,324.7426,852,518.23-32.35%归属于上市公司股东的扣除非经常性损益的净利润（元）2,899,545.506,207,108.972,034,130.0242.54%经营活动产生的现金流量净额（元）67,886,098.549,333,575.169,146,646.10642.20%基本每股收益（元/股）0.01210.02060.0178-32.02%稀释每股收益（元/股）0.01210.02060.0178-32.02%加权平均净资产收益率0.33%0.57%0.49%-0.16%本报告期末上年度末本报告期末比上年度末增减调整前调整后调整后总资产（元）17,288,636,016.5416,012,320,005.0216,037,471,948.367.80%归属于上市公司股东的净资产（元）5,355,003,490.145,537,791,736.875,548,487,656.81-3.49%